¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

[¿Â¶óÀÎ] Á¦23ȸ Çѱ¹Æ÷µµ¸·ÇÐȸ ½ÉÆ÷Áö¾ö : 2022-05-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
[¿Â¶óÀÎ] Á¦23ȸ Çѱ¹Æ÷µµ¸·ÇÐȸ ½ÉÆ÷Áö¾ö : 2022-05-14
±³À°ÀÏÀÚ : 2022-05-14
±³À°Àå¼Ò : ¿Â¶óÀÎ ½ºÆ®¸®¹Ö  
±³À°ÁÖÁ¦ : [¿Â¶óÀÎ] Á¦23ȸ Çѱ¹Æ÷µµ¸·ÇÐȸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹Æ÷µµ¸·ÇÐȸ  
´ã´çÀÚ : Á¤À¯¸®
¿¬¶ôó : 031-219-7815  
À̸ÞÀÏ : cyr216@hanmail.net      
±³À°Á¾·ù : ¾È°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Á¤È¸¿ø(ȸºñ ¿Ï³³ ½Ã): ¹«·á / ºñȸ¿øÀü¹®ÀÇ: 50,000¿ø Àü°øÀÇ, °ü°èÀÚ: 20,000¿ø  ÀÇÇù È®Àοë ID:kma / PW: 1234      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-14  09:00~09:12 Dilemma in Real-world Clinical Practice: Anterior Uveitis  ¹Úö¿ë(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 05-14  09:12~09:24 Dilemma in Real-world Clinical Practice: Posterior Uveitis  ¿ì¼¼ÁØ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-14  09:24~09:36 HLA Associated Ocular Inflammatory Diseases  Á¤Çý¿ø(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 05-14  09:36~09:48 Drug Delivery and Local Therapies for Uveitis  ÀÌÁ¾Çö(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 05-14  09:48~10:00 Establishing the Evidence: Key Clinical Trials in Uveitis  ¾ÈÁöÀ±(¼­¿ïÀÇ´ë) 
Åä·Ð 05-14  10:00~10:20 Q&A  ÁÂÀå(ÀÌÁ¾Çõ/À¯½Â¿µ)(¿øÁÖÀÇ´ë/°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-14  10:25~10:45 Immune Response to COVID-19 or Vaccination  ¹Ú¿Ï¹ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-14  10:45~11:00 COVID-19-related Anterior Inflammation  ±è¹Ì±Ý(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-14  11:00~11:15 COVID-19-related Posterior Inflammation  À̽±Ô(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-14  11:15~11:30 Treatment of Uveitis in COVID-19 Patients  ¹èÁ¤ÈÆ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 05-14  11:30~11:50 Q&A  ÁÂÀå(ÇÔµ·ÀÏ/¼­°æ·ü)(¼º±Õ°üÀÇ´ë/¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-14  12:40~12:55 Ocular Surface Complications in Uveitis  ±èÀ¯Á¤(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 05-14  12:55~13:10 Cataract in Uveitis  ±è°æ¿ì(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 05-14  13:10~13:25 Glaucoma in Uveitis  ÇϾƴÃ(Á¦ÁÖÀÇ´ë) 
±³À°½Ã°£ 05-14  13:25~13:40 Uveitic Macular Edema  ÀÌÁÖ¿ë(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-14  13:40~13:55 Vitreoretinal Complications in Uveitis  ±è¹Î(¿¬¼¼ÀÇ´ë) 
Åä·Ð 05-14  13:55~14:15 Q&A  ÁÂÀå(À̼ºÃ¶/ÀÌÇü±Ù)(°Ç¾çÀÇ´ë/¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-14  14:20~14:30 Infectious Scleritis  ÀüÀÍÇö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-14  14:30~14:40 °©Àڱ⠴«ÀÌ º×°í ¾ÆÆļ­ ³»¿øÇÑ 60¼¼ SLE ȯÀÚ  À̱âȲ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 05-14  14:40~14:50 Endogenous Endophthalmitis: Round Up the Usual Suspects  À±Ã¶¹Î(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 05-14  14:50~15:00 ´« ¸Åµ¶¿¡ µ¿¹ÝµÈ °ßÀθÁ¸·¹Ú¸®  ±ÇÀ±Çü(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 05-14  15:00~15:10 Impact of Optic Disc Hyperfluorescence on Retina and Optic Nerve Head Thickness in Patients with Uveitis  ¹è°ÇÈ£(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-14  15:10~15:20 Retinal Vasculitis  ¹Ú¿µÁÖ(°­¿øÀÇ´ë) 
±³À°½Ã°£ 05-14  15:20~15:30 Floating Cysticercosis Cyst  ±è¿ëÁØ(¿¬¼¼ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" [¿Â¶óÀÎ] Á¦23ȸ Çѱ¹Æ÷µµ¸·ÇÐȸ ½ÉÆ÷Áö¾ö : 2022-05-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)2022³â Á¦4Â÷ ½ºÆ÷Ã÷ÀÇÇÐ ÆÀÁÖÄ¡ÀÇ ½ÉÈ­±³À°°úÁ¤ : 2022-05-14
´ÙÀ½±Û ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ (¿Â¶óÀÎ) 2022³â Á¦1Â÷ ÇÁ·ÎÆ÷Æú ÁøÁ¤±³À° : 2022-05-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20853 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¤Çü¿Ü°ú Á¦21ȸ SMC Orthopedic Symposium 2024 : 2024-06-23 0 10 2024-05-27
20852 ÀÎõ Á¦3ȸ ÀÎÇϴ뺴¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò : 2024-06-22 0 19 2024-05-27
20851 °æ±â (¿Â¶óÀÎ) Á¦7ȸ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾îÁö·³Áõ¼¾ÅÍ ¿¬¼ö°­Á : 2024-06-22 0 32 2024-05-27
20850 ±¤ÁÖ 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22 0 17 2024-05-27
20849 ¼­¿ï ´ëÇÑÃé´ãµµÇÐȸ [¿Â¶óÀÎ] Pancreato-Biliary Summer School 2024 (PB-SS) : 2024-06-22 0 17 2024-05-27
20848 ¼­¿ï Á¦26Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : °áÇÙ°ú ºñ°áÇÙÇ×»ê±Õ ÆóÁúȯÀÇ ÃÖ½ÅÁö°ß : 2024-06-22 0 29 2024-05-27
20847 ¼­¿ï Á¦3ȸ Severance Orthopaedic Review(¼¼ºê¶õ½º ±Ù°ñ°Ý ¿¬¼ö°­ÁÂ) : 2024-06-22 0 11 2024-05-27
20846 ¼­¿ï (¿Â¶óÀÎ)2024³â ¼­´ë¹®±¸ÀÇ»çȸ ¿Â¶óÀÎÇмú´ëȸ : 2024-06-22 0 20 2024-05-27
20845 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 2ÀÏÂ÷ : 2024-06-22 0 22 2024-05-27
20844 ´ë±¸ 2024³â Á¦ 23ȸ ´ëÇѵΰ³¾È¸é¼ºÇü¿Ü°úÇÐȸ Ãá°è½ÉÆ÷Áö¾ö : 2024-06-22 0 13 2024-05-27
20843 ¼­¿ï µ¿ÀÛ±¸ÀÇ»çȸ ÀÇÇÐ ¿¬¼ö±³À°(¸¸¼ºÁúȯ, Å»¸ð¿Í ÇǺΰü¸®, »ý¼ºÇü AI Æ®·»µå¿Í ÀÇ·á, ÀÇ·áºÐÀï) : 2024-06-22 0 18 2024-05-27
20842 ¼­¿ï (¿Â¶óÀÎ) °øȲ¹üºÒ¾ÈÀå¾Ö Ä¡·áÀÇ ½ÉÃþÀû Á¢±Ù : 2024-06-22 0 12 2024-05-27
20841 °æ±â 2024³â ´ëÇѳëÀκñ´¢ÀÇÇÐȸ Á¦7Â÷ Á¤±âÇмú´ëȸ : 2024-06-22 0 13 2024-05-27
20840 ¼­¿ï (¿Â¶óÀÎ) Á¦34Â÷ ´ëÇѼҾÆÀÓ»ó¸é¿ªÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 22 2024-05-27
20839 ´ë±¸ 2024 ´ë±¸±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 31 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷